Overview

Prospan® Hustenzäpfchen - Investigation on Efficacy and Tolerability in Children

Status:
Unknown status
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The aims of this study are - Demonstrating superior efficacy of Prospan® Hustenzäpfchen compared to Placebo in children suffering from acute bronchitis accompanied by coughing - Characterisation of safety and tolerability of Prospan® Hustenzäpfchen in comparison with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Engelhard Arzneimittel GmbH & Co.KG